Search

Author/Creator Pollentier, Stephane

1. A randomized Phase II trial evaluating efficacy, safety, and tolerability of oral BI 409306 in attenuated psychosis syndrome: Design and rationale. Issue 5 (22nd December 2020)

Authors:
Keefe, Richard S. E.; Woods, Scott W.; Cannon, Tyrone D.; Ruhrmann, Stephan; Mathalon, Daniel H.; McGuire, Philip; Rosenbrock, Holger; Daniels, Kristen; Cotton, Daniel; Roy, Dooti; Pollentier, Stephane; Sand, Michael
Journal:
Early intervention in psychiatry
Issue:
Volume 15:Issue 5(2021)
Page Start:
1315
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Diagnostic criteria for apathy in neurocognitive disorders. Issue 12 (5th May 2021)

Authors:
Miller, David S.; Robert, Philippe; Ereshefsky, Larry; Adler, Lawrence; Bateman, Daniel; Cummings, Jeff; DeKosky, Steven T.; Fischer, Corinne E.; Husain, Masud; Ismail, Zahinoor; Jaeger, Judith; Lerner, Alan J.; Li, Abby; Lyketsos, Constantine G.; Manera, Valeria; Mintzer, Jacobo; Moebius, Hans J...
Journal:
Alzheimer's & dementia
Issue:
Volume 17:Issue 12(2021)
Page Start:
1892
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Efficacy and safety of the novel glycine transporter inhibitor BI 425809 once daily in patients with schizophrenia: a double-blind, randomised, placebo-controlled phase 2 study. (March 2021)

Authors:
Fleischhacker, W Wolfgang; Podhorna, Jana; Gröschl, Martina; Hake, Sanjay; Zhao, Yihua; Huang, Songqiao; Keefe, Richard S E; Desch, Michael; Brenner, Ronald; Walling, David P; Mantero-Atienza, Emilio; Nakagome, Kazuyuki; Pollentier, Stephane
Journal:
Lancet
Issue:
Volume 8:Number 3(2021)
Page Start:
191
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Evaluation of the efficacy and safety of orally administered BI425809 during a 12‐week treatment period compared with placebo in patients with cognitive impairment due to Alzheimer's disease: Human: Putative therapeutic results for Alzheimer's and related dementias. (7th December 2020)

Authors:
Wunderlich, Glen; Blahova, Zuzana; Garcia, Miguel; Huang, Songqiao; Pollentier, Stephane; Jessen, Frank
Journal:
Alzheimer's & dementia
Issue:
Volume 16(2020)Supplement 9
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. S40. COMBINING PHARMACOTHERAPY OF BI 425809 WITH COMPUTERISED COGNITIVE TRAINING IN PATIENTS WITH SCHIZOPHRENIA: INITIAL EXPERIENCE OF A LARGE-SCALE MULTICENTRE RANDOMISED CLINICAL TRIAL. (18th May 2020)

Authors:
Hake, Sanjay; Huang, Songqiao; McDonald, Sean; Pollentier, Stephane; Podhorna, Jana
Journal:
Schizophrenia bulletin
Issue:
Volume 46(2020)Supplement 1
Page Start:
S47
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗